The network is a major component of the National Cancer Institute’s response to the pandemic and is included in an emergency Congressional appropriation of $306 million to the Institute “to develop, validate, improve and implement serological testing and associated technologies.”
Other News
Is COVID-19 over? COVID-19 continues; however, there are a few new twists:
COVID-19 rates are going up.
Please take a moment to think about what you can do to prepare to protect yourself and the people around you.
Resources that will allow you to assess the current situation and make choices about your personal safety.